CG Oncology CGON Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Commercial And Development Revenue | $1.07M— | $1.73M— | $1.51M— | $0— | $0— | |
| License And Collaboration Revenue | $14K-73.1% | $596K+30.7% | $158K+267% | $0— | $52K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CG Oncology break its business down?
- CG Oncology (CGON) reports revenue (gross) by product across 2 parts — Commercial And Development Revenue and License And Collaboration Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does CG Oncology's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CG Oncology's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.